TOKYO SHINJUKU HEMOPHILIA CENTER

The Hemophilia Treatment Center (HTC) in Tokyo Medical University Hospital is providing a comprehensive care for hemophilia and
other coagulation disorders, working with related departments. We are operating outpatient clinic from Mon. to Fri. (8:30-16:00) and
Sat. (8:30-11:00) except 2nd & 4th Sat. We have emergency care systems for 24hrs.

Director:
Dr. Katsuyuki Fukutake , Professor and Chairman of Laboratory Medicine
Physicians:
Dr. Kagehiro Amano, Dr. Masato Binngo, Dr. Yuushi Chikasawa, Dr. Takeshi Hagiwara, Dr. Akito Ichiki, Dr.Yoshiko Kamikobo
Dr.Takashi Muramatsu, Dr. Kyoichi Ogata, Dr. Tsuyoshi Oishi, Dr. Manabu Otaki, Dr Takashi Suzuki,
Dr. Taijiro Shirokawa, Dr. Mihoko Yotsumoto
Nurse Coordinator:
Ms. Chie Sato RN
BioMedical Researchers
Dr. Hiroshi Inaba, Ph.D., Dr. Keiko Shinozawa, Ph.D.*
*Dept. of Molecular Genetics of Coagulation Disorders

Address:
Tokyo Shinjuku Hemophilia Centre
Department of Laboratory Medicine, Tokyo Medical University Hospital
6-7-1 Nishi-shinnjuku, Shinjuku-Ku, Tokyo, Japan, 160-0023
Phone: +81-3-3342-6111
Fax: +81-3-3340-5448
Email: fukutake@tokyo-med.ac.jp
Web site:http://labo-med.tokyo-med.ac.jp/
Japanese-English Medical Information Form for Travelers with bleeding disorders
word -- PDF -- JPEG
MAP
PDF -- JPEG
Available Coagulation factor Products
Factor VIII:
Recombinant; Advate , Adynovate (Baxalta), Kovaltry (Bayer), Novo Eight(Novo Nordisk), Eloctate(Bioverativ)
Plasma; Cross-eightM(Japan Blood Products Organization)
Factor IX
Recombinant; Benefix(Pfyzer), Alprolix(Bioverativ) , Idelvion (CSL Behring)
Plasma; Novact M (Kaketsuken), Christmasin M (Japan Blood Products Organization)
Factor VII
NovoSeven (Novo Nordisk)
Inhibitor;
FEIBA (Baxter), NovoSeven (Novo Nordisk), Byclot(Kaketsuken)
VWF;
Plasma; Confact F ( Kaketsuken )
Factor XIII;
Plasma; Fibrogamin(CSL)